The cyclin dependent kinase inhibitor p21<sup>Cip1/Waf1</sup> is a therapeutic target in high-risk neuroblastoma.

Front Oncol · 2022 · PMC9486206 · PMID 36147919

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

When further investigating the expression of p-p21, a possible trend towards a reverse correlation to p21 was observed, however this was not significant ( Figure 1G ).

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.